Shanghai Huiyong Pharmaceutical

Shanghai Huiyong Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and commercialization of high-end drug delivery systems. The company is a leader in complex formulation technologies, including osmotic pump controlled-release, multi-particulate sustained-release, and solid dispersion for poorly soluble drugs. Huiyong Pharmaceutical provides a full suite of R&D services, ranging from early-stage formulation design to clinical trial management and regulatory submission. Their internal pipeline and service offerings primarily address chronic diseases such as hypertension, diabetes, and central nervous system disorders. By optimizing the pharmacokinetic profiles of established molecules, the company aims to enhance therapeutic efficacy and patient adherence.